Table 1.

Effects of prenatal exposure to phthalate mixture on body weight, tissue weight, and occurrence of grossly visible cystic ovaries in the F3 generation of 13 month old female mice

F3 Generation
	Treatment
Body Weight (g)	Control	46.01 ± 3.32
	20 μg/kg/day	46.73 ± 3.65
	200 μg/kg/day	51.28 ± 3.58
	200 mg/kg/day	49.19 ± 2.72
	500 mg/kg/day	40.47 ± 2.26
Single Ovary Weight (g)	Control	0.0080 ± 0.0010
	20 μg/kg/day	0.0148 ± 0.0006*
	200 μg/kg/day	0.0092 ± 0.0015
	200 mg/kg/day	0.0118 ± 0.0019
	500 mg/kg/day	0.0072 ± 0.0010
Uterine Weight (g)	Control	0.2041 ± 0.0244
	20 μg/kg/day	0.2337 ± 0.0228
	200 μg/kg/day	0.2192 ± 0.0239
	200 mg/kg/day	0.2278 ± 0.0402
	500 mg/kg/day	0.2786 ± 0.0131
Liver Weight (g)	Control	2.5658 ± 0.1604
	20 μg/kg/day	2.7343 ± 0.1709
	200 μg/kg/day	2.9306 ± 0.2055
	200 mg/kg/day	2.7714 ± 0.1444
	500 mg/kg/day	2.4965 ± 0.0760
AGD (mm)/∛Body Weight (g)	Control	1.7313 ± 0.0665
	20 μg/kg/day	1.7435 ± 0.0506
	200 μg/kg/day	1.5799 ± 0.0972
	200 mg/kg/day	1.6454 ± 0.0721
	500 mg/kg/day	1.6727 ± 0.1193
Percent Grossly Visible Cystic Ovaries (%)	Control	33.3
	20 μg/kg/day	44.4
	200 μg/kg/day	33.3
	200 mg/kg/day	33.3
	500 mg/kg/day	50.0

Asterisks (*) indicate significant differences compared to the control (p < 0.05).